Sec Form 4 Filing - Monarch Alternative Capital LP @ PYXUS INTERNATIONAL, INC. - 2023-02-21

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Monarch Alternative Capital LP 2. Issuer Name and Ticker or Trading Symbol PYXUS INTERNATIONAL, INC. [ PYX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner _____ Officer (give title below) X __ Other (specify below) See Remarks (Last) (First) (Middle) 535 MADISON AVENUE, 26TH FLOOR 3. Date of Earliest Transaction (MM/DD/YY) 02/21/2023 (Street) NEW YORK, NY10022 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, no par value ("Common Stock") 02/21/2023 S 15,199 D $ 1.34 0 I See footnotes ( 1 ) ( 2 ) Common Stock 2,985,982 I See footnotes ( 1 ) ( 3 ) Common Stock 265,261 I See footnotes ( 1 ) ( 4 ) Common Stock 1,897,178 I See footnotes ( 1 ) ( 5 ) Common Stock 976,650 I See footnotes ( 1 ) ( 6 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Monarch Alternative Capital LP 535 MADISON AVENUE 26TH FLOOR NEW YORK, NY10022 X X See Remarks MDRA GP LP C/O MONARCH ALTERNATIVE CAPITAL LP 535 MADISON AVENUE, 26TH FLOOR NEW YORK, NY10022 X X See Remarks Monarch GP LLC C/O MONARCH ALTERNATIVE CAPITAL LP 535 MADISON AVENUE, 26TH FLOOR NEW YORK, NY10022 X X See Remarks Signatures MONARCH ALTERNATIVE CAPITAL LP; By: MDRA GP LP, its General Partner; By: Monarch GP LLC, its General Partner; By: /s/ Christopher Santana, Member 02/23/2023 Signature of Reporting Person Date MDRA GP LP; By: Monarch GP LLC, its General Partner; By: /s/ Christopher Santana, Member 02/23/2023 Signature of Reporting Person Date MONARCH GP LLC; By: /s/ Christopher Santana, Member 02/23/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )See Exhibit 99.1 ( 2 )See Exhibit 99.1 ( 3 )See Exhibit 99.1 ( 4 )See Exhibit 99.1 ( 5 )See Exhibit 99.1 ( 6 )See Exhibit 99.1

Remarks: Sale resulting from client-specific mandate. Monarch Alternative Capital LP, a Delaware limited partnership ("MAC"), appointed Patrick Bartels to the board of directors of the Issuer as its designee pursuant to Section 2.1(d) of the Shareholders Agreement. As a result, each of MAC, and by virtue of their control of MAC, MDRA GP LP and Monarch GP LLC, may be deemed to be a "director-by-deputization" of the Issuer solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.Exhibit List:Exhibit 99.1 - Explanation of Responses

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.